Form 4: Nucor Executive Reports 7,200-Share Sale at $146
Rhea-AI Filing Summary
Nucor Corp (NUE) reporting person Daniel R. Needham, Executive Vice President, filed a Form 4 reporting an open-market sale of company common stock. The filing shows a sale of 7,200 shares on 08/18/2025 at a price of $146 per share. Following the transaction the filing reports beneficial ownership of 92,179.37 shares held directly. The form was signed by an attorney-in-fact on behalf of Mr. Needham on 08/20/2025.
Positive
- Timely, complete disclosure of insider sale including date, price, and post-transaction holdings
- Clear identification of reporting person and relationship to issuer (Executive Vice President)
Negative
- Officer disposed of 7,200 shares, which may attract investor attention though no motive or plan is disclosed
- No explicit mention in the filing whether the sale was executed under a Rule 10b5-1 plan or preclearance
Insights
TL;DR: Insider sale of 7,200 shares at $146 is disclosed; transaction appears routine and timely.
The Form 4 documents a single non-derivative sale by an executive officer, specifying share count, execution date, and price. The reported post-transaction direct ownership is 92,179.37 shares, which provides transparency about the officer's remaining stake. There is no information in this filing about the reason for the sale, any contemporaneous stock plan, or any hedging arrangements. Absent additional context, this disclosure alone is informational rather than demonstrably material to Nucor's operations or financial condition.
TL;DR: Filing complies with Section 16 reporting requirements; timely signature by attorney-in-fact noted.
The Form 4 records required details: reporting person identity, relationship to issuer (Executive Vice President), transaction date, transaction code (sale), number of shares sold, price per share, and resulting direct beneficial ownership. The signature block shows an attorney-in-fact executed the filing on 08/20/2025, consistent with authorized filing practices. The document does not disclose whether the sale was part of a pre-arranged Rule 10b5-1 plan or any internal trading preclearance, so governance reviewers cannot determine whether the sale followed an established plan.